EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allele-Skewed HLA-DR Immunopeptidomes of Bordetella pertussis

Hooman Yari iD, Saghar Kaabinejadian iD, Ricardo da Silva Antunes iD, Sandra K Armstrong, Timothy J Brickman, Alessandro Sette iD, William H Hildebrand

Vaccines · 25.08.2026 · 14 (9) · 733

DOI: 10.3390/vaccines14090733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 25.08.2026. Verfasst von Hooman Yari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, College of Medicine, The University of Oklahoma Health Campus, Oklahoma City, OK 73104, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, La Jolla Institute for Immunology under National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Infection with Bordetella pertussis causes whooping cough. CD4+ T cell responses depend on bacterial peptides displayed by HLA class II, yet allele- and strain-resolved maps of naturally processed B. pertussis HLA-DR ligands remain limited. We sought to define which antigens yield HLA-DR ligands in a human macrophage model and whether presentation is skewed by HLA-DR molecule and bacterial strain.

Methods

THP-1–derived macrophages were pulsed with whole-cell lysates of B. pertussis vaccine/reference strain Tohama I or clinical isolate D420. HLA-DR was immunoaffinity purified; eluted peptides were identified by LC-MS/MS and assigned to HLA-DR molecules encoded by HLA-DRB1*01:01, HLA-DRB1*15:01, and HLA-DRB5*01:01.

Results

We identified 63 B. pertussis peptide ligands from 29 source proteins. Presentation was skewed by HLA-DR molecule: DRB1*01:01 accounted for 37 ligands from 21 antigens, DRB1*15:01 for 22 from 7, and DRB5*01:01 for 4 from 4. Most source proteins contributed ligands primarily to one HLA-DR molecule, so an antigen that supplies peptides to one DR product need not supply peptides to another. Strain further partitioned the ligandome: 32 ligands unique to Tohama I, 12 to D420, and only 19 from 8 proteins with both lysates. Only three antigens contributed ligands to both DRB1*01:01 and DRB1*15:01; two of these, pertactin and filamentous hemagglutinin, are components of current acellular pertussis vaccines.

Conclusions

B. pertussis HLA-DR ligandomes are jointly shaped by bacterial strain and HLA-DR molecule. Antigens can interact selectively with individual HLA-DR products, and peptides from a given antigen may be recovered after pulse with one strain but not another. These findings support HLA-DR and strain-aware interpretation of class II presentation and nominate BrkA autotransporter (Bordetella resistance to killing A), outer membrane protein A (OmpA), tracheal colonization factor (TcfA), and a divalent metal transporter (DMT) family transporter for follow-up.

Schlagwörter

Stichwörter der Autor:innen

Bordetella pertussisHLA-DRacellular pertussis vaccineantigen presentationimmunopeptidomicspeptide ligand

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, College of Medicine, The University of Oklahoma Health Campus, Oklahoma City, OK 73104, USA.
  • Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
  • Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
  • Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA 92093, USA.

ORCID-Profile: Hooman Yari, Saghar Kaabinejadian, Ricardo da Silva Antunes, Alessandro Sette

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • La Jolla Institute for Immunology under National Institutes of Health

Zitieren

APA

Yari, H., Kaabinejadian, S., da Silva Antunes, R., Armstrong, S. K., Brickman, T. J., Sette, A., & Hildebrand, W. H. (2026). Allele-Skewed HLA-DR Immunopeptidomes of Bordetella pertussis. Vaccines, 14(9), 733. https://doi.org/10.3390/vaccines14090733

Vancouver

Yari H, Kaabinejadian S, da Silva Antunes R, Armstrong SK, Brickman TJ, Sette A, et al. Allele-Skewed HLA-DR Immunopeptidomes of Bordetella pertussis. Vaccines. 2026;14(9):733. doi:10.3390/vaccines14090733

BibTeX
@article{Yari2026,
  author = {Yari, Hooman and Kaabinejadian, Saghar and da Silva Antunes, Ricardo and Armstrong, Sandra K and Brickman, Timothy J and Sette, Alessandro and Hildebrand, William H},
  title = {Allele-Skewed HLA-DR Immunopeptidomes of Bordetella pertussis},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {9},
  pages = {733},
  doi = {10.3390/vaccines14090733}
}
Kostenlos starten →